Reducing Blood Pressure in Patients With High Cardiovascular Risk
BP-REACH
BP-REACH: Blood Pressure Disparities Reduction, Equity, and Access Among Safety Net Patients With Cardiovascular Health Risk
1 other identifier
interventional
546
1 country
4
Brief Summary
BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are:
- Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care?
- Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2023
CompletedFirst Posted
Study publicly available on registry
July 10, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
May 14, 2025
May 1, 2025
2.8 years
June 30, 2023
May 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic blood pressure (SBP) mmHG
Collected by study staff using blood pressure monitor
12 months
Secondary Outcomes (7)
Life's Essential 8
12 months
BMI (body mass index)
12 months
Total cholesterol
12 months
HgbA1c (hemoglobin A1C)
12 months
Diet
12 months
- +2 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants receive the usual care received by patients of the medical center
Intervention
EXPERIMENTALParticipants follow the intervention protocol, including receiving educational materials, a home blood pressure monitor, coaching calls from BP REACH coaches and medication management from a pharmacist.
Interventions
Educational materials, written and digital. Home blood pressure monitor and self management education from BP REACH coach. Monthly coaching calls from BP REACH coach. Medication management by pharmacist
Eligibility Criteria
You may qualify if:
- Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction
- English or Spanish speaking
- Systolic blood pressure (SBP) ≥ 130 mm Hg
You may not qualify if:
- Age \< 35 years
- SBP \< 130 mm Hg
- Only speaks a language other than English or Spanish
- Cannot provide informed consent due to dementia or aphasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- University of California, Los Angelescollaborator
- University of California, Irvinecollaborator
Study Sites (4)
Rancho Los Amigos National Rehabilitation Center
Downey, California, 90242, United States
LA General Medical Center
Los Angeles, California, 90033, United States
Olive View Medical Center
Sylmar, California, 91342, United States
Harbor UCLA Medical Center
Torrance, California, 90502, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alejandra Casillas, MD
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Amytis Towfighi, MD
University of Southern California
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 30, 2023
First Posted
July 10, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share